台股 » 個股 » 生華科 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

生華科

(6492)
可現股當沖
  • 股價
    44.30
  • 漲跌
    ▲0.05
  • 漲幅
    +0.11%
  • 成交量
    103
  • 產業
    上櫃 生技醫療類股
  • 154人加入追蹤

    立即追蹤

  • 本地時間:13:35(已收盤)

     
生華科 (6492)籌碼相關-國票-中和 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

國票-中和 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/02/14145.0000.0044.8011630.61%
2025/01/2200.00242.6042.30-2228-0.88%
2025/01/20241.6000.0041.6523780.53%
2025/01/09145.10144.7043.9503860.00%
2024/12/25142.6000.0042.6014410.23%
2024/12/19942.2300.0042.5094841.86%
2024/12/16142.3500.0042.3515850.17%
2024/12/06144.1500.0044.1516110.16%
2024/12/02145.2500.0045.4016340.16%
2024/11/2900.00246.0046.05-2639-0.31%
2024/11/27444.4500.0044.2046550.61%
2024/11/18244.7000.0044.1026990.29%
2024/11/14146.6000.0046.4517050.14%
2024/11/08148.6000.0048.6017350.14%
2024/10/30250.9000.0050.5027770.26%
2024/10/2900.00152.1052.10-1772-0.13%
2024/10/285555.355453.5152.6017560.13%
2024/10/2500.00254.3554.40-2645-0.31%
2024/09/192154.7700.0053.20219952.11%
2024/09/1800.00150.5052.30-1943-0.11%
2024/09/10147.1000.0046.9011,0390.10%
2024/09/0900.00148.7548.20-11,034-0.10%
2024/09/05247.3500.0047.4021,0180.20%
2024/09/04248.6000.0047.8521,0170.20%
2024/09/0200.00450.9050.70-41,003-0.40%
2024/08/30451.4000.0051.3049990.40%
2024/08/222949.962950.7549.8009620.00%
2024/08/2000.00150.8050.90-1943-0.11%
2024/08/1900.00250.2049.80-2930-0.21%
2024/08/16349.55649.8350.10-3928-0.32%
2024/08/155148.354848.9049.6039170.33%
2024/08/13347.0700.0047.1038940.34%
2024/08/071050.951151.2350.70-1856-0.12%
2024/08/0600.006950.0049.00-69841-8.20%
2024/08/056748.4500.0047.70678188.18%
2024/07/31156.5000.0056.5017990.13%
2024/07/2900.00257.8556.90-2788-0.25%
2024/07/26252.9000.0054.5027760.26%
2024/07/23256.60255.7054.1007700.00%
2024/07/2200.00757.0056.20-7752-0.93%
2024/07/19860.21558.6058.1037350.41%
2024/07/185459.234761.1862.2076581.06%
2024/07/1600.00456.9857.20-4427-0.94%
2024/07/1200.00947.2347.30-9328-2.74%
2024/07/09243.4300.0043.4023190.63%
2024/07/08645.171545.3044.70-9315-2.86%
2024/07/04244.7500.0044.8523100.64%
2024/07/03145.3000.0045.0013080.32%
2024/07/011847.5400.0047.10183025.96%
2024/06/2600.00149.3048.75-1288-0.35%
2024/06/2100.00145.9545.20-1258-0.39%
2024/06/1900.00245.9047.95-2224-0.89%
2024/06/1800.001044.6644.00-10213-4.68%
2024/06/171045.20245.1545.3581874.27%
2024/06/1200.001142.1541.80-11152-7.23%
2024/06/07142.6000.0042.6011510.66%
2024/05/23142.1000.0042.1011720.58%
2024/05/22143.2500.0043.2511740.57%
2024/05/21142.5500.0042.5511730.58%
2024/05/14141.4000.0041.6011790.56%
2024/04/29741.43041.4041.3071833.82%
2024/04/26140.7000.0040.7011820.55%
2024/04/22040.81040.8140.6501870.00%
2024/04/18042.0000.0041.9001820.00%
2024/03/29143.5000.0044.1011980.51%
2024/03/26144.0000.0043.0512020.49%
2024/03/25044.5500.0044.5002010.00%
2024/03/21444.1000.0042.7042001.99%
2024/03/12143.2500.0043.6012140.47%
2024/03/0400.00543.8043.60-5339-1.47%
2024/02/27745.16245.0045.0053731.34%
2024/02/26045.7000.0045.8003790.00%
生華科新藥再獲孤兒藥資格 上市可獲7年市場獨賣保護期Anue鉅亨-2024/10/25
上櫃「肥貓」董監現形 台嘉碩、大宇資、穩懋、生華科為前四肥Anue鉅亨-2024/04/15
生華科治療新冠、流感等泛病毒感染新藥 將啟動二期臨床Anue鉅亨-2023/11/21
生華科 相關文章
生華科 相關影音